Fatal Systemic Reaction after Multiple Doses of Intravesical Bacillus Calmette-Guérin for Polyposis

Author:

Peyrière Hélène1,Klouche Kada2,Béraud Jean-Jacques3,Blayac Jean-Pierre4,Hillaire-Buys Dominique5

Affiliation:

1. Hélène Peyrière PharmD PhD, Clinical Pharmacist, Center of Pharmacovigilance, Saint-Charles Hospital, Montpellier, France

2. Kada Klouche MD, Hospital Physician, Metabolic Intensive Care Unit, Lapeyronie Hospital, Montpellier

3. Jean-Jacques Béraud MD, Hospital Physician, Metabolic Intensive Care Unit, Lapeyronie Hospital

4. Jean-Pierre Blayac MD, Professor in Clinical Pharmacology, Center of Pharmacovigilance, Saint-Charles Hospital

5. Dominique Hillaire-Buys MD PhD, Lecturer in Clinical Pharmacology, Center of Pharmacovigilance, Saint-Charles Hospital

Abstract

OBJECTIVE: To report a case of fatal systemic reaction after intravesical administrations of bacillus Calmette-Guérin (BCG) for polyposis. CASE SUMMARY: A 72-year-old white man was treated by monthly injections of intravesical BCG immunotherapy for polyposis of the urinary bladder. He received a total of eight injections; four hours after the seventh injection, he presented with pyrexia associated with chills, sweating, headache, and vomiting, which quickly resolved. Four hours after the eighth injection, the patient presented with the same symptoms plus a left-hemisphere deficiency. Results of a cerebral scan performed at this time were normal. The clinical status of the patient quickly worsened, with the appearance of disseminated intravascular coagulation, acute anuric renal insufficiency, rhabdomyolysis, hemolysis, and cytolytic and cholestatic hepatitis. The patient required hemodialysis and symptomatic treatment. Lactic acidosis with hemolytic—uremic syndrome appeared, and he died as the result of a multivisceral (respiratory, renal, hepatic) deficiency. DISCUSSION: The patient presented with symptoms compatible with a severe systemic reaction to BCG therapy, a rare but possible adverse effect. CONCLUSIONS: BCG instillation is a valuable tool in the therapy of bladder carcinoma, but increasing reports of severe adverse reactions should continue to remind practicing urologists to be alert to the possibility of common and uncommon reactions after its use.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3